[18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review
Open Access
- 8 August 2018
- journal article
- case report
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 109
Abstract
Semantic variant primary progressive aphasia (svPPA) is a subtype of primary progressive aphasia characterized by two-way anomia and disturbance in word comprehension, with focal atrophy in the left temporal lobe. [18F]THK-5351 was originally developed to trace tau protein. However, it has recently been suggested that [18F]THK-5351 binds to monoamine oxidase B in astrocytes, which reflects gliosis. Herein, the authors present two cases involving patients with early-stage svPPA who underwent [18F]THK-5351 positron emission tomography (PET) imaging, and examined whether [18F]THK-5351 PET imaging is more sensitive to neurodegenerative lesions than conventional imaging modalities such as magnetic resonance imaging (MRI) and cerebral blood flow (CBF)-single photon emission computed tomography (SPECT). Two patients, 64- and 79-year-old men, without notable medical or family history, exhibited disturbances in word comprehension and mild anomia with fluent speech and spared repetition. In both cases, surface dyslexia was observed but prosopagnosia was absent. Although mild depression was detected in 1 of the 2 patients, no behavioral disorders were present in either case. In both cases, MRI revealed atrophy in the anterior and inferior portions of the left temporal lobe. Technetium-99-ethyl cysteinate dimer ([99mTc]ECD) SPECT revealed hypoperfusion in the left temporal lobe. Alzheimer’s disease was ruled out by [11C]Pittsburgh Compound-B (PiB) PET scan. Both patients fulfilled the diagnostic criteria for svPPA. Because of mild language deficits and lack of right temporal atrophy, they were considered to be at an early stage of the disease. In both cases, [18F]THK-5351 retention was observed in bilateral temporal lobes, predominantly on the left side. Comparison of different imaging modalities suggested that [18F]THK-5351 was more sensitive in detecting neurodegenerative change in the right temporal lobe than MRI and [99mTc]ECD SPECT. [18F]THK-5351 retention was clearly demonstrated at an early stage of svPPA. Results of the present study suggest that [18F]THK-5351 PET imaging may facilitate very early diagnosis of the disease.Keywords
Funding Information
- Grant-in-Aid for Scientific Research (15H04900, 26117003)
This publication has 17 references indexed in Scilit:
- [18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive AphasiaAlzheimer Disease & Associated Disorders, 2018
- Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer DiseaseJournal of Nuclear Medicine, 2017
- Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PETNeurology, 2016
- Tau imaging with [18F]THK‐5351 in progressive supranuclear palsyEuropean Journal of Neurology, 2016
- Astroglial Activation and Tau Hyperphosphorylation Precede to Neuron Loss in a Neurodegenerative Mouse ModelCNS Neuroscience & Therapeutics, 2016
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer DiseaseJournal of Nuclear Medicine, 2015
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implicationsJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Classification of primary progressive aphasia and its variantsNeurology, 2011
- An easy Z-score imaging system for discrimination between very early Alzheimer??s disease and controls using brain perfusion SPECT in a multicentre studyNuclear Medicine Communications, 2007